Sponsor

Beth Israel Deaconess Medical Center

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Beth Israel Deaconess Medical Center appears in 277 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials277
Recruiting shown14
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
The CARDIOPROTECT TrialNCT07654426 · lead sponsor · 2026-08-31
RECRUITING
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersNCT06896474 · lead sponsor · 2026-02-04
RECRUITING
Groceries for Residents of Southeastern USA to Stop HypertensionNCT06891911 · lead sponsor · 2025-10-14
RECRUITING
Remote Fetal Monitoring in High Risk PregnanciesNCT06822439 · lead sponsor · 2025-05-01
RECRUITING
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HFNCT05934565 · lead sponsor · 2025-04-28
RECRUITING
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for PsychosisNCT06542640 · lead sponsor · 2024-01-01
RECRUITING
Cognitive Neurology Unit Clinical RegistryNCT05925621 · lead sponsor · 2023-07-16
RECRUITING
Biomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesNCT06740383 · lead sponsor · 2023-01-01
RECRUITING
Avecure Flexible Microwave Ablation Probe For Lung NodulesNCT05281237 · lead sponsor · 2022-06-01
RECRUITING
Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume ReductionNCT05257681 · lead sponsor · 2022-05-24
RECRUITING
Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in EmphysemaNCT04801108 · lead sponsor · 2021-08-01
RECRUITING
The Physiology of Human Brown Adipose TissueNCT04352244 · lead sponsor · 2020-03-05
RECRUITING
Purinergic Signaling and the Postmenopausal HeartNCT06015776 · lead sponsor · 2019-07-01
RECRUITING
Prevalence and Impact of Obstructive Sleep Apnea in Multiple SclerosisNCT04603196 · lead sponsor · 2019-06-20
RECRUITING
Gastrointestinal Dopamine Decarboxylase and Levodopa PharmacokineticsNCT07793461 · lead sponsor · 2027-07-01
NOT_YET_RECRUITING
Effect of PEEP on Cardiac FunctionNCT07531602 · lead sponsor · 2026-06-17
ENROLLING_BY_INVITATION
PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear MicroscopyNCT07516808 · lead sponsor · 2026-06-01
NOT_YET_RECRUITING
Testing Conversation Aid in PracticeNCT06011434 · lead sponsor · 2024-05-06
COMPLETED
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in BotswanaNCT05986084 · lead sponsor · 2023-11-30
ACTIVE_NOT_RECRUITING
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen ExpressionNCT05683964 · lead sponsor · 2023-01-19
ACTIVE_NOT_RECRUITING
Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical StimulationNCT05445466 · lead sponsor · 2022-12-16
COMPLETED
Accelerated TMS in PsychosisNCT05567848 · lead sponsor · 2022-11-29
SUSPENDED
Yoga for Mental Health in Parkinson's PatientsNCT05335850 · lead sponsor · 2022-10-18
COMPLETED
Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated HypertensionNCT05393232 · lead sponsor · 2022-10-13
COMPLETED
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated HypertensionNCT05121337 · lead sponsor · 2022-09-30
COMPLETED
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in SchizophreniaNCT05282186 · lead sponsor · 2022-09-02
COMPLETED
Alcohol and Breast Cancer (ABC) TrialNCT05423730 · lead sponsor · 2022-09-01
COMPLETED
Sodium Nitroprusside in Early Course SchizophreniaNCT04986072 · lead sponsor · 2022-03-14
TERMINATED
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and PainNCT05803096 · lead sponsor · 2021-12-12
COMPLETED
Improving Hallucinations by Targeting the rSTS With tESNCT05165654 · lead sponsor · 2021-11-01
COMPLETED
Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in SchizophreniaNCT07190352 · lead sponsor · 2021-10-04
COMPLETED
Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)NCT04321759 · lead sponsor · 2021-06-01
UNKNOWN
Neratinib in Patients With Metastatic Castration-Resistant Prostate CancerNCT04781374 · lead sponsor · 2021-05-21
WITHDRAWN
Home Air Purification for Eosinophilic COPDNCT04252235 · lead sponsor · 2021-03-15
COMPLETED
Feasibility Electrical Stimulation Study for Visual HallucinationsNCT04870710 · lead sponsor · 2020-10-01
COMPLETED
Sleep Ventilation for Patients With Advanced Hypercapnic COPDNCT04210050 · lead sponsor · 2020-09-30
WITHDRAWN
Take Off Pounds After Stroke Trial (TOPS)NCT03815214 · lead sponsor · 2019-12-01
COMPLETED
Effect of a Plant Rich Diet on in People With Type 2 Diabetes and ObesityNCT02977039 · lead sponsor · 2019-11-01
WITHDRAWN
Treating Hyperexcitability in AD With LevetiracetamNCT03875638 · lead sponsor · 2019-08-22
COMPLETED
Neurological Impacts of Artificial Sweeteners in the Context of Diet SodasNCT04048681 · lead sponsor · 2019-08-06
COMPLETED
Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear MicroscopyNCT02926729 · lead sponsor · 2019-07-17
TERMINATED
Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of SchizophreniaNCT03648268 · lead sponsor · 2019-05-02
TERMINATED
Mindful Steps: Promoting Physical ActivityNCT03003780 · lead sponsor · 2019-01-02
COMPLETED
Thiamine as Adjunctive Therapy for Diabetic KetoacidosisNCT03717896 · lead sponsor · 2018-11-21
COMPLETED
Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department PatientsNCT03736421 · lead sponsor · 2018-11-10
TERMINATED
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate CancerNCT03637543 · lead sponsor · 2018-10-18
ACTIVE_NOT_RECRUITING
Traxi Panniculus Retractor for Cesarean DeliveryNCT03651076 · lead sponsor · 2018-10-02
TERMINATED
Imaging Markers of Subclinical Cardiotoxicity in Breast CancerNCT02666378 · lead sponsor · 2018-09-10
COMPLETED
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer ScreeningNCT03482557 · lead sponsor · 2018-05-17
COMPLETED
2-stage Cervical Cancer Screening in BotswanaNCT03324009 · lead sponsor · 2018-04-20
COMPLETED
Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer ScreeningNCT03495115 · lead sponsor · 2018-04-18
COMPLETED
Olaparib In Metastatic Breast CancerNCT03344965 · lead sponsor · 2018-04-01
ACTIVE_NOT_RECRUITING
Moderate Alcohol and Cardiovascular Health TrialNCT03169530 · lead sponsor · 2018-02-05
TERMINATED
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of DiabetesNCT02915263 · lead sponsor · 2017-09-11
TERMINATED
Breast Cancer Risk Assessment in Women Aged 40-49NCT03180086 · lead sponsor · 2017-07-01
COMPLETED
Optimizing HIV PrEP Through Shared Decision MakingNCT03019770 · lead sponsor · 2017-02-24
COMPLETED
Mechanisms Underlying the Blood Pressure Lowering Effect of SleepNCT03043963 · lead sponsor · 2017-02-10
COMPLETED
Saxenda: Underlying Mechanisms and Clinical OutcomesNCT02944500 · lead sponsor · 2016-11-01
ACTIVE_NOT_RECRUITING
Surgical vs. Lifestyle in Obese Older AdultsNCT03137329 · lead sponsor · 2016-07-01
TERMINATED
A Breast Cancer Treatment Decision Aid for Women Aged 70 and OlderNCT02823262 · lead sponsor · 2016-07-01
TERMINATED

Drugs studied in this sponsor's trials

81 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Beth Israel Deaconess Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo25
cyclophosphamide10
bevacizumab8
cisplatin6
docetaxel6
carboplatin5
doxorubicin5
paclitaxel5
placebo RxCUI 8375 · Lead sponsor in 16 linked trial(s) · 0 currently recruiting 25 trials cyclophosphamide RxCUI 3002 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 10 trials bevacizumab RxCUI 253337 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 8 trials cisplatin RxCUI 2555 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 6 trials docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 6 trials carboplatin RxCUI 40048 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 5 trials doxorubicin RxCUI 3639 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 5 trials paclitaxel RxCUI 56946 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 5 trials Herceptin RxCUI 101306 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 4 trials trastuzumab RxCUI 224905 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 4 trials bicalutamide RxCUI 83008 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials capecitabine RxCUI 194000 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials eszopiclone RxCUI 461016 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 3 trials leptin RxCUI 1441651 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials cetuximab RxCUI 318341 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials erlotinib RxCUI 337525 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials fulvestrant RxCUI 282357 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials letrozole RxCUI 72965 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials liraglutide RxCUI 475968 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials methotrexate RxCUI 6851 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials Navelbine RxCUI 53557 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials prednisone RxCUI 8640 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 2 trials vinorelbine RxCUI 39541 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials Abraxane RxCUI 589511 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor148
collaborator129
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.